Moderna CEO Predicts People Will Get Covid Vaccines Every Year Like “An iPhone”
"We think we can put in a single product a lot of mRNAs, taking care of all those viruses. And that's once a year," Moderna CEO described.
Think pharmaceutical companies are done profiting off of Covid? Think again.
Moderna plans to introduce new experimental jabs that will combine flu, Covid and RSV vaccines in one yearly shot, the company’s CEO told CNN International.
Discussing the terrifying prospect of an all-in-one jab, Moderna CEO Stéphane Bancel compared people lining up to get the shot to the craze seen nearly every year over the latest Apple iPhone.
Moderna hopes to roll out a single-dose annual booster to cover the coronavirus, the flu and another common respiratory virus within the next five years — evolving like 'an iPhone'
“We think we can put in a single product a lot of mRNAs, taking care of all those viruses. And that’s once a year,” Bancel described.
“You should be able to get an annual booster, single dose, that has, in the vial, all those mRNAs for all those [viruses] that are, of course adapted to the strain of a season, like flu, like Covid strain, and so on.”
The CEO next said that, much like an iPhone improves slightly with every new model, vaccine manufacturers would also be adapting their experimental mRNA jabs with “the best science of the moment.”
“And the idea is a bit like the iPhone, whereas, you know, a lot of us buy a new iPhone every September. And you get new apps, and you get refreshed apps,” Bancel said.
“And that’s exactly the same idea, which is you’ll get Covid and Flu and RSV in your single dose. And you’ll get what’s the best science of the moment to protect you for the strain circulating now and in the fall, winter. So we can combine all those things and provide to people around the world the annual booster. So only one shot. And they don’t worry about the winter. And they have a nice fall and winter.”
Asked what the timeframe is for the release of an experimental all-in-one jab, Bancel said some countries could begin introducing the technology as early as next year.
“So it would take a few years. You know, as I said, flu and RSV are in phase three [clinical trials]. So I can see some countries in ’23 starting to have flu and Covid in a single dose, both in single dose. Some countries will be ’24. So I think it’ll take us a few years.”
“That’s why I did the iPhone analogy, which is you don’t get the amazing camera… amazing everything the first time you get an iPhone, but you get a lot of things already,” he said.
“But I think within a three-to-five years window where every year, you will get a better product from Moderna that will protect you for all the things circulating and with more and more coverage of different viruses.”
Back in March, Bancel complained to the World Economic Forum that his company was having to “throw away” 30 million doses of their Covid-19 vaccine because people were rejecting the vaccine and “nobody wants them.”
In addition to side effects linked to the Pfizer and AstraZeneca Covid jabs, Infowars has reported on various instances where Moderna’s vaccine has been suspected of causing severe adverse reactions that resulted in illness and even death.
Time will tell whether the incoming experimental jabs will also carry the same risks.